mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |